Co-Authors
This is a "connection" page, showing publications co-authored by Piotr P. Witkowski and Rolf Barth.
Connection Strength
1.529
-
Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience. Clin Transplant. 2023 05; 37(5):e14981.
Score: 0.232
-
Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress. Front Endocrinol (Lausanne). 2021; 12:789526.
Score: 0.213
-
207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Transplantation. 2021 12 01; 105(12 Suppl 1):S3.
Score: 0.212
-
The Impact of COVID-19 on Kidney Transplant Recipients in Pre-Vaccination and Delta Strain Era: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Sep 30; 10(19).
Score: 0.209
-
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States. Am J Transplant. 2021 07; 21(7):2620-2622.
Score: 0.202
-
COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. Clin Transplant. 2021 04; 35(4):e14246.
Score: 0.201
-
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375.
Score: 0.200
-
Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study). J Clin Med. 2023 Sep 06; 12(18).
Score: 0.060